George Jarad is a Nephrology physician. OpenAlex indexes 31 publications with 2,402 citations (h-index 21).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Saint George Regional Hospital
1380 E. Medical Center Dr
Saint George, UT 84790
Telephone
435-688-6358Provider last certified this registry record 18 Apr 2024.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20251 payment
- Merck Sharp & Dohme LLCProgram year20241 payment
- Vifor Pharma, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
60%Beta blocker15.1%Carvedilol60%Metoprolol Succinate27%Atenolol7%Metoprolol Tartrate7%Part D<11 patientsLoop diuretic9%Furosemide86%Torsemide14%Part D<11 patients+ 9 more classes in this area
Metabolism & gastrointestinal
16.4%Vitamin D3 Analog5.5%Calcitriol100%Part D≥17 patientsSGLT2 inhibitor4.1%Jardiance50%Farxiga50%Part D<11 patients+ 4 more classes in this area
Blood & clotting
8.8%Solutions for parenteral nutrition4.4%Calcium Acetate100%Part D≥15 patientsP2Y12 inhibitor2.2%Clopidogrel100%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Blocking CHOP-dependent TXNIP shuttling to mitochondria attenuates albuminuria and mitigates kidney injury in nephrotic syndrome
Proceedings of the National Academy of Sciences
2022 - POS-629 ANAPHYLAXIS SECONDARY TO CITRIC ACID ALLERGY IN END STAGE KIDNEY DISEASE PATIENTS
Kidney International Reports
2022 - Blocking CHOP-Dependent TXNIP Shuttling to Mitochondria Attenuates Albuminuria and Mitigates Kidney Injury in Nephrotic Syndrome
Journal of the American Society of Nephrology
2022 - Anaphylaxis Secondary to Citric Acid Allergy in ESKD Patients
Journal of the American Society of Nephrology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Giuseppe Remuzzi
Mario Negri Institute for Pharmacological Research
Marcello Tonelli
University of Calgary
Johan Ärnlöv
Dalarna University
Juan Jesús Carrero
Danderyds sjukhus
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”